小分子蛋白酶激活:已知刺激剂的比较结构分析
Jaida M Osman1, Darci J Trader2
1Department of Chemistry, University of California, Irvine, CA 92617, United States.
Bioorganic & medicinal chemistry
|November 12, 2025
概括
随着年龄的增长,蛋白质酶的活性会下降,破坏细胞的健康. 本综述分析了已知的蛋白酶体刺激剂,以指导对与年龄相关疾病的新疗法的开发,并增强细胞健康.
科学领域:
- 生物化学 生物化学
- 细胞生物学 细胞生物学
- 分子医学是分子医学.
背景情况:
- 蛋白质酶对真核细胞中的蛋白质降解至关重要.
- 随着年龄的增长,蛋白质酶活性下降导致蛋白质稳定性破坏和疾病.
- 增强蛋白酶体活性可以改善细胞健康,治疗疾病.
研究的目的:
- 审查和分析已知的蛋白酶体刺激器的结构特征.
- 确定趋势和关键的结构动机,以开发更强大的激活剂.
- 为了进一步了解治疗应用的蛋白酶体刺激.
主要方法:
- 对现有的蛋白酶体刺激剂的文献综述.
- 已识别的化合物的结构分析.
- 确定共同的结构特征和趋势.
主要成果:
- 目前的蛋白酶体刺激剂经常从其他治疗领域重新使用.
- 分析揭示了与蛋白质酶激活相关的特定结构动机.
- 趋势表明,有可能设计出新的,更强大的刺激剂.
结论:
- 对于专门开发为蛋白质酶激活剂的新型小分子有很大的需求.
- 了解结构-活性关系是设计有效的蛋白酶体刺激器的关键.
- 这一分析为开发针对蛋白质酶体功能的新疗法提供了基础.
更多相关视频
07:22Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes
Published on: January 12, 2024
4.4K
08:31Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
5.5K
相关概念视频
The Proteasome Structure
1.6K
The ubiquitin-proteasome pathway is a well-known mechanism utilized by eukaryotic cells to remove cytoplasmic proteins that are misfolded, damaged, or no longer needed. In this pathway, the protein that needs to be eliminated undergoes a process called ubiquitination, where a chain of ubiquitin molecules is attached to the 48th lysine residue of the target protein. This ubiquitin modification helps the proteasome distinguish between a target protein and a healthy protein.
The proteasome is an...
The proteasome is an...
1.6K
Ligand Binding and Linkage
5.4K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
5.4K
Allosteric Proteins-ATCase
6.4K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
6.4K
The Proteasome
10.0K
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
10.0K
The Proteasome
1.6K
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
1.6K
The Proteasome
4.4K
4.4K
